DLA Piper advises Quipt Home Medical in shareholder activist matter

DLA Piper advised Quipt Home Medical Corp. (Quipt), a US-based home medical equipment provider focused on end-to-end respiratory care, in an amicable resolution to an activist shareholder matter. Quipt had received a notice from a shareholder indicating its intent to solicit proxies in support of four alternative director candidates to Quipt’s Board of Directors in opposition to Quipt’s four director candidates.

DLA Piper advised Quipt throughout this activist process ultimately resulting in Quipt entering into a cooperation agreement with David Kanen, Philotimo Fund, LP, and Kanen Wealth Management, LLC (collectively Kanen).

Under the terms of the agreement, Kanen withdrew its notice of its intent to solicit proxies in support of four director candidates at Quipt’s upcoming 2025 annual general meeting of shareholders in opposition to the director candidates recommended by Quipt.

The DLA Piper team was led by partners Larry Nishnick (San Diego) and Robbie Grossman and Sydney Kert (Toronto).

With more than 1,000 corporate lawyers globally, DLA Piper helps clients execute complex transactions seamlessly while supporting clients across all stages of development. The firm has been rated number one in global M&A volume for 15 consecutive years, according to Mergermarket, and ranked as a top five most active VC legal advisor in the US and number one in VC, PE and M&A in combined global deal volume according to PitchBook.